中梁控股:發行2.5億美元優先票據 年利率降至歷史新低7.5%
格隆匯1月26日丨中梁控股(2772.HK)今日發佈公吿稱公司成功發行於2022年到期的2.5億美元票據,最終年息率成功定價7.5%,降至歷史新低,突顯受資本市場及廣大投資者認可。
對此,惠譽授予此筆票據“B+”評級,與公司的高級無抵押評級保持一致。惠譽表示,中梁的評級是由其合同銷售規模支撐的,與“BB”級住宅建築商相當,公司項目遍佈中國五個核心經濟區,地域多元化程度較高,增長勢頭強勁,近年穩居行業20強。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.